Influenza Infected Articles & Analysis
16 articles found
Welcome to 2023-2024 season’s respiratory surveillance recap, where we’ll share insights from the most recent respiratory surveillance season, covering three major respiratory viruses: COVID-19, influenza, and RSV. Tracking these illnesses is imperative for maintaining population health because these illnesses significantly impact individual wellbeing and healthcare costs, resource ...
Subsequent studies found that this LNP, when loaded with mRNA encoding a broadly neutralizing antibody against coagulase, could protect mice from H1N1 influenza infection. 3) Local injection refers to the administration of drugs to a small area of the body. ...
With zapnometinib’s favorable outcome in a recent phase II clinical trial in hospitalized COVID-19 patients, the present results are even more promising for an upcoming phase II clinical trial in severe influenza virus infection. 1 Introduction As of today, virus infections, especially those with pandemic potential, still pose a major ...
Application in the treatment of influenza Introduction of influenza Influenza, also called flu or grippe, is an acute viral infection of the upper or lower respiratory tract. ...
The clinical presentation of COVID-19-related illness ranges from asymptomatic to mild respiratory symptoms resembling influenza infection to acute symptoms including pneumonia requiring hospitalization and admission to the intensive care unit. ...
We plan to develop sublingual interferon-alfa for the prevention of viral infections, such as influenza and coronaviruses (such as COVID-19). The rise in prevalence of viral respiratory infections in humans and increase in health care expenditure are projected to boost the growth of the global respiratory antiviral treatment market. ...
COVID-19 shares similarities with other respiratory infections, yet we still have a limited understanding of the immune response to SARS-CoV-2. ...
MADISON, Wis., Sept. 7, 2022 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the completion of enrollment of the first cohort in an age de-escalation clinical trial of M2SR (M2 Deficient Single Replication) live virus vaccine, the company’s investigational supra-seasonal intranasal ...
Virus infection and transmission endanger human health and socio-economic development. Influenza is a respiratory infection caused by the influenza virus. Influenza viruses are antigenically variable, spread rapidly, and can cause seasonal epidemics each year. ...
Last week, the product manager of Creative Enzymes announced the launch of neuraminidase, which is expected to further develop a new universal influenza vaccine. Neuraminidase is a drug target to prevent the spread of influenza infection. ...
“CoroFlu will also express the influenza virus hemagglutinin protein, which is the major influenza virus antigen, so we should get immune responses to both coronavirus and ...
Moreover, independent of nicotine, ENDS-exposed mice infected with influenza demonstrated enhanced lung inflammation and tissue damage. ...
However, gastrointestinal symptoms developed in a large proportion of influenza A (H1N1) 2009 virus infected people during the pandemic in 2009 and fecal shedding was reported. This fecal route could potentially play a role in the entry of human pathogenic influenza viruses in to the water cycle. Monitoring of influenza viruses ...
We find that during and after the SARS influenza crisis, stock market returns of the infected countries exhibited significant increase in co-integrated relationship and dynamic co-movements, compared to the pre-SARS period. ...
We present our methodology and stochastic discrete-event simulation developed to model the screening of passengers for pandemic influenza at the US port-of-entry airports. Our model uniquely combines epidemiology modelling, evolving infected states and conditions of passengers over time, and operational considerations of screening in a single simulation. ...
The issue of hospital acquired infections is a serious problem. According to several sources, three to four million hospital-acquired infections occur annually, with up to 80,000 fatalities. ...